ENACT-REACT COVID (long term follow up)

ENACT-REACT COVID (long term follow up)

Start Date:

March 2020

End Date:

March 2021

Duration:

24 months

ID-CARE Role:

Website:

Leader

Description

Title: follow-up of patients with COVID-19.

Design: longitudinal prospective study.

Primary Objective: to assess long term symptoms and quality of life of patients recovering from COVID-19.

Secondary Objective: to assess potential easy-to-use questionnaires administered via structured phone interviews that would be useful to study the long-term sequelae of COVID-19.

Partners

Univeristy of Verona

Sponsor

Publications

Biomedicines

2/11/22

Impact of COVID-19 and antibiotic treatments on Gut Microbiome: a role for Enterococcus spp.

Learn More

BMC Infectious Diseases

28/8/21

Assessment of COVID-19 progression on day 5 from symptoms onset.

Learn More

European journal of clinical microbiology & infectious diseases

20/6/22

Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study

Learn More

Blood

5/11/20

✰

Serological prevalence of Sars-Cov-2 infection among chronic Myeloid Leukemia patients undergoing Tyrosine Kinase inhibitor treatment in Italy (COVID-19-HEM study)

Learn More

Journal of Infection

6/2/22

✰

Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study

Learn More